Nuevocor

Developer of gene therapies for the treatment of cardiovascular disease

placeSingapore, Singapore, Singapore calendar_todayFounded 2021 groups28 employees language nuevocor.com

Registered entities

Social engagement

Social engagement: 2.9K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include EVX Ventures, Boehringer Ingelheim Venture Fund, Kurma Partners, Angelini Ventures.

Investor typeCountShare
Venture capital778%
Other / undisclosed222%

Recent activity

17 Jun 2026
Event
BIO 2026
16 Jun 2026
Partnership
SG Growth Capital
12 May 2026
Expansion
Paris
Coming soon